Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin add-on to insulin in adults with LADA
ChiCTR1800016049Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Jan 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in latent autoimmune diabetes in adults (LADA) comparing Metformin + insulin with Insulin alone (2 arms). Primary endpoints: HbA1c and C-peptide. Started Jan 2014; status: completed.
02
Drugs
metforminhuman insulin
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on ChiCTR1800016049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016049.